Literature DB >> 2309740

Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis.

R L Mehta1, G Scott, J A Sloand, C W Francis.   

Abstract

PURPOSE: To determine if the natural anticoagulant protein C plays a role in the pathogenesis of systemic calciphylaxis, a syndrome characterized by extensive vascular and soft tissue calcification and skin necrosis, which is similar to that seen in warfarin-induced skin necrosis. PATIENTS AND METHODS: The study population included five patients with end-stage renal disease and systemic calciphylaxis undergoing hemodialysis, 12 patients without evidence of calciphylaxis undergoing dialysis, eight patients with nephrotic syndrome, and eight normal healthy volunteers. Protein C antigen levels were measured by rocket immunoelectrophoresis, and functional activity was quantitated by a chromogenic assay and an anticoagulant assay utilizing the venom of Agkistrodon contortrix.
RESULTS: Skin biopsy specimens of involved areas in three patients showed thrombotic occlusion of venules identical to that seen in warfarin-induced skin necrosis. Protein C antigen levels were normal in all groups. However, protein C activity was significantly reduced as measured by chromogenic (p less than 0.01) or anticoagulant assays (p less than 0.01) in patients with calciphylaxis compared with the other three groups.
CONCLUSION: These findings suggest that hypercoagulability due to functional protein C deficiency may contribute to thrombosis, resulting in skin necrosis and digital gangrene in systemic calciphylaxis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2309740     DOI: 10.1016/0002-9343(90)90150-c

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Fatal calciphylaxis in two patients with giant cell arteritis.

Authors:  K Brouns; E Verbeken; H Degreef; H Bobbaers; D Blockmans
Journal:  Clin Rheumatol       Date:  2006-07-27       Impact factor: 2.980

2.  Painful skin ulcers in a hemodialysis patient.

Authors:  Stuart M Sprague
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

3.  Calciphylaxis in pediatric end-stage renal disease.

Authors:  Abubakr A Imam; Tej K Mattoo; Gaurav Kapur; David A Bloom; Rudolph P Valentini
Journal:  Pediatr Nephrol       Date:  2005-08-25       Impact factor: 3.714

4.  Calciphylaxis: a condition mimicking necrotizing vasculitis.

Authors:  M Melikoglu; S Apaydin; V Hamuryudan; S Yurdakul; N Uygun; H Aki; G Ozbay; H Yazici
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

Review 5.  Calciphylaxis.

Authors:  R V Mathur; J R Shortland; A M el-Nahas
Journal:  Postgrad Med J       Date:  2001-09       Impact factor: 2.401

6.  [Calciphylaxis. Pathogenesis and therapy].

Authors:  N-P Hoff; B Homey
Journal:  Hautarzt       Date:  2011-07       Impact factor: 0.751

7.  Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism.

Authors:  Susumu Matsuoka; Susumu Matstusoka; Yoshihiro Tominaga; Nobuaki Uno; Norihiko Goto; Tetsuhiko Sato; Akio Katayama; Toshihito Haba; Kazuharu Uchida; Keiko Kobayashi; Akimasa Nakao
Journal:  World J Surg       Date:  2005-05       Impact factor: 3.352

8.  Surviving calciphylaxis.

Authors:  Paul Lee; Jacob Sevastos; Lesley V Campbell
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

Review 9.  Coumarin-induced skin necrosis. Incidence, mechanisms, management and avoidance.

Authors:  P C Comp
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

10.  Treatment of severe metastatic calcification and calciphylaxis in dialysis patients.

Authors:  Saurabh K Goel; Keith Bellovich; Peter A McCullough
Journal:  Int J Nephrol       Date:  2011-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.